STOCK TITAN
  1. Home
  2. PLPRF

Plus Prods (PLPRF) Stock Price, News & Analysis

PLPRF OTC
Published by Stock Titan Data refreshed

What Changed

Company Description

Plus Prods (OTC: PLPRF) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.8B.

This page collects what Stock Titan holds for PLPRF, including price data and latest news.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
$1.8B
Market Cap
43.3M
Shares outstanding

PLPRF Metrics & Rankings

Market Cap
$1.8B
View ranking

Latest News

View All
—

Glass House Brands to Acquire PLUS, a Leading California Edibles Brand

acquisition
—

Plus Products Obtains Extension of Stay Period and Claims Process Order Under the Companies’ Creditors Arrangement Act (Canada)

—

Plus Products Reveals Dual Action Sleep gummies featuring first combined fast acting, long lasting formulation

—

Plus Products Files for Creditor Protection Under the Companies’ Creditors Arrangement Act and Cancels September 14 Annual General Meeting

—

Plus Products Achieves Record Quarterly Sales, Reports Second Quarter 2021 Financial Results

earnings
—

Plus Products Releases Preliminary Unaudited Second Quarter 2021 Revenue, Announces Date for the Release of Second Quarter 2021 Results, Conference Call and Webcast

conferences earnings
—

Plus Products Announces Return of Limited-Edition Hash-Based Gummies

—

Plus Products Inc Announces Resignation of Director Matt Schmidt After 3 Years of Service

management
—

PLUS Products Files Early Warning Report on Behalf of Director, Matt Schmidt

—

Plus Products Re-Launches Best-Selling Limited Edition Gummies for Pride 2021, Collaborates with Transgender, Gender-Variant and Intersex Justice Project

Plus Prods has 10 recent news articles. Key topics include acquisition, earnings, conferences, management. View all PLPRF news →

SEC Filings

View All

No SEC filings available for PLPRF.

Related Stocks

EMBCV EMBCV
1.9B
BCRX BioCryst Pharmaceuticals Inc
2.0B
PAHC Phibro Animal Health Corporation
1.6B
HLUKF H Lundbeck
4.9B
AVDL Avadel Pharmaceuticals plc
2.1B
BGM BGM Group Ltd.
119.8M
HROW Harrow, Inc.
1.1B
AMPH Amphastar Pharmaceuticals, Inc.
1.1B

PLPRF Company Profile & Sector Positioning

Plus Prods (PLPRF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing PLPRF often look at related companies in the same sector, including EMBCV (EMBCV), BioCryst Pharmaceuticals Inc (BCRX), Phibro Animal Health Corporation (PAHC), H Lundbeck (HLUKF), and Avadel Pharmaceuticals plc (AVDL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PLPRF's relative position within its industry.

Frequently Asked Questions

What is the market cap of Plus Prods (PLPRF)?

The market cap of Plus Prods (PLPRF) is approximately $1.8B. Learn more about what market capitalization means .